GSK Investigational Site

Sosnowiec 41-200

0 studies enrolling now · 4 studies all time

What they study most

Anaemia, Deep Vein Thrombosis, Fibrillation, Atrial, Pulmonary Disease, Chronic Obstructive, Pulmonary Embolism, Venous Thromboembolism

Studies at this site

• Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level — Completed
• Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ) — Completed
• Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) — Stopped early
• Odiparcil For The Prevention Of Venous Thromboembolism — Completed